PD1 Antibody [7H6] (HRP) Cat. No.: RF16003-HRP

Availability: In stock

$0.00

 Price Options

$0.00
psi-iconSpecifications
HOST SPECIES:Mouse
SPECIES REACTIVITY: Human
IMMUNOGEN: PD-1 antibody (HRP) was raised against the extracellular domain of human PD-1.
TESTED APPLICATIONS: ELISA
APPLICATIONS: PD1 antibody can be used for as detection antibody in Sandwich Elisa at 1 μg/mL.
POSITIVE CONTROL:1) Cat. No. 1306 - Human Spleen Tissue Lysate
 2) Cat. No. 1315 - Human Tonsil Tissue Lysate
 3) Cat. No. 1369 - Human Lymph node Tissue Lysate
 4) Cat. No. 10-901 - Human Spleen Tissue Slide
 5) Cat. No. 10-001 - Human Breast Tissue Slide
 6) Cat. No. 17-010 - HEK293 Cell Slide
PREDICTED MOLECULAR WEIGHT: Predicted: 32 kDa

Observed: 38 kDa

psi-iconProperties
PURIFICATION:PD-1 Antibody (HRP) is supplied as protein A purified IgG1.
CLONALITY:Monoclonal
ISOTYPE:IgG1
CONJUGATE:HRP
PHYSICAL STATE:Liquid
BUFFER:PD-1 Antibody (HRP) is supplied in PBS containing 1% BSA and 0.02% thimerosol.
CONCENTRATION:1 mg/mL
STORAGE CONDITIONS:PD-1 Antibody (HRP) can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

psi-iconAdditional Info
OFFICIAL SYMBOL:PDCD1
ALTERNATE NAMES:HRP-PD-1 Antibody: PD1, PD-1, CD279, SLEB2, hPD-1, hPD-l, hSLE1, PD1, Programmed cell death protein 1, Protein PD-1, PDCD1, PDCD-1
ACCESSION NO.:NP_005009
PROTEIN GI NO.:145559515
GENE ID:5133
USER NOTE:Optimal dilutions for each application to be determined by the researcher.
psi-iconBackground and References
BACKGROUND:Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins.
REFERENCES:1) Holling TM, Schooten E, and van Den Elsing PJ. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Hum. Immunol. 2004; 65:282-90.
2) Ishida Y, Agata Y, Shibahara K, et al. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992; 11:3887-95.
3) Zhong X, Bai C, Gao W, et al. Suppression of expression and function of negative immune regulator PD-1 by certain pattern recognition and cytokine receptor signals associated with immune system danger. Int. Immunol. 2004; 16:1181-8.
4) Nishimura H, Nose M, Hiai H, et al. Development of lupus-like autoimmune diseases by the disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11:141-51.

ANTIBODIES FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.